Can-Fite Share Price
AMEX: CANF | Others$1.47
+$1.47 (--%) Last updated on 20 Nov, 2026 | 01:46 ISTCan-Fite Stock Performance
Can-Fite Share Price Chart
$1.47$1.47
L
H
Corporate Actions
About Can-Fite
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
Can-Fite Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.63 | $1.47 | -12.50% |
Oct 2026 | $2.20 | $1.68 | -24.32% |
Sep 2026 | $3.20 | $2.22 | -35.75% |
Aug 2026 | $3.52 | $3.46 | +5.66% |
Jul 2026 | $4.89 | $3.27 | +14.34% |
Jun 2026 | $3.25 | $2.86 | -16.37% |
May 2026 | $3.04 | $3.42 | +8.57% |
Apr 2026 | $3.18 | $3.15 | +1.61% |
Mar 2026 | $4.83 | $3.10 | -35.01% |
Feb 2026 | $4.14 | $4.77 | +17.78% |
Jan 2026 | $0.19 | $4.05 | +1,935.18% |
Dec 2025 | $0.34 | $0.20 | -43.30% |